Who makes Reference capsule GDC-0134?

Reference capsule GDC-0134 is developed by Genentech, Inc..

What development phase is Reference capsule GDC-0134 in?

Reference capsule GDC-0134 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Reference capsule GDC-0134

Genentech, Inc. · Phase 1 active Small molecule

At a glance

Generic name	Reference capsule GDC-0134
Sponsor	Genentech, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants (PHASE1)
A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Reference capsule GDC-0134 CI brief — competitive landscape report
Reference capsule GDC-0134 updates RSS · CI watch RSS
Genentech, Inc. portfolio CI